Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Prostate Cancer Clinical Trials Consortium

Clinical trials sponsored by Prostate Cancer Clinical Trials Consortium, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

DNA registry aims to decode how inherited genes shape prostate cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1

New hope for Hard-to-Treat prostate cancer: drug combo trial launches

Disease control Not yet recruiting

This phase 2 trial tests whether adding mevrometostat to enzalutamide can slow cancer growth in 60 men with metastatic castration-resistant prostate cancer who have already been treated with similar drugs. Participants will take both drugs orally. The main goal is to see how long…

Phase 2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC